These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 32139154)

  • 21. Effect of Neurohormonal Blockade Drug Therapy on Outcomes and Left Ventricular Function and Structure After Left Ventricular Assist Device Implantation.
    Grupper A; Zhao YM; Sajgalik P; Joyce LD; Park SJ; Pereira NL; Stulak JM; Burnett JC; Edwards BS; Daly RC; Kushwaha SS; Schirger JA
    Am J Cardiol; 2016 Jun; 117(11):1765-70. PubMed ID: 27079215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Redo sternotomy versus left ventricular assist device explant as risk factors for early mortality following heart transplantation.
    Ribeiro RVP; Alvarez JS; Fukunaga N; Yu F; Adamson MB; Foroutan F; Cusimano RJ; Yau T; Ross H; Alba AC; Billia F; Badiwala MV; Rao V
    Interact Cardiovasc Thorac Surg; 2020 Nov; 31(5):603-610. PubMed ID: 33137824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Copeptin in Heart Failure, Post-Left Ventricular Assist Device and Post-Heart Transplantation.
    Zabarovskaja S; Hage C; Gabrielsen A; Mellbin L; Lund LH
    Heart Lung Circ; 2017 Feb; 26(2):143-149. PubMed ID: 27523461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severity of oxidative stress and inflammatory activation in end-stage heart failure patients are unaltered after 1 month of left ventricular mechanical assistance.
    Caruso R; Verde A; Campolo J; Milazzo F; Russo C; Boroni C; Parolini M; Trunfio S; Paino R; Martinelli L; Frigerio M; Parodi O
    Cytokine; 2012 Jul; 59(1):138-44. PubMed ID: 22579113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for heart transplantation and left ventricular assist system: results from the ScrEEning for advanced Heart Failure treatment (SEE-HF) study.
    Lund LH; Trochu JN; Meyns B; Caliskan K; Shaw S; Schmitto JD; Schibilsky D; Damme L; Heatley J; Gustafsson F
    Eur J Heart Fail; 2018 Jan; 20(1):152-160. PubMed ID: 28960673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in disease-specific versus generic health status measures after left ventricular assist device implantation: Insights from INTERMACS.
    Nassif ME; Spertus JA; Jones PG; Fendler TJ; Allen LA; Grady KL; Arnold SV
    J Heart Lung Transplant; 2017 Nov; 36(11):1243-1249. PubMed ID: 28662987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-33/ST2 pathway and classical cytokines in end-stage heart failure patients submitted to left ventricular assist device support: a paradoxic role for inflammatory mediators?
    Caselli C; D'Amico A; Ragusa R; Caruso R; Prescimone T; Cabiati M; Nonini S; Marraccini P; Del Ry S; Trivella MG; Parodi O; Giannessi D
    Mediators Inflamm; 2013; 2013():498703. PubMed ID: 24385685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Effect of Left Ventricular Assist Device Therapy on Cardiac Biomarkers: Implications for the Identification of Myocardial Recovery.
    Holzhauser L; Kim G; Sayer G; Uriel N
    Curr Heart Fail Rep; 2018 Aug; 15(4):250-259. PubMed ID: 29971612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of percutaneous veno-arterial extracorporeal membrane oxygenation as bridge to left ventricular assist device.
    Toda K; Fujita T; Seguchi O; Yanase M; Nakatani T
    J Artif Organs; 2018 Mar; 21(1):39-45. PubMed ID: 28871334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of normalization strategy on cardiac expression of pro-inflammatory cytokines: evaluation of reference genes in different human myocardial regions after Left Ventricular Assist Device support.
    Caselli C; D'Amico A; Caruso R; Cabiati M; Prescimone T; Cozzi L; Cannata A; Parodi O; Del Ry S; Giannessi D
    Cytokine; 2013 Aug; 63(2):113-22. PubMed ID: 23669252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart failure etiology and risk of right heart failure in adult left ventricular assist device support: the European Registry for Patients with Mechanical Circulatory Support (EUROMACS).
    Løgstrup BB; Nemec P; Schoenrath F; Gummert J; Pya Y; Potapov E; Netuka I; Ramjankhan F; Parner ET; De By T; Eiskjaer H
    Scand Cardiovasc J; 2020 Oct; 54(5):306-314. PubMed ID: 32552049
    [No Abstract]   [Full Text] [Related]  

  • 32. Short-term mechanical unloading and reverse remodeling of failing hearts in children.
    Mohapatra B; Vick GW; Fraser CD; Clunie SK; Towbin JA; Sinagra G; Vatta M
    J Heart Lung Transplant; 2010 Jan; 29(1):98-104. PubMed ID: 19783184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury.
    Ahmad T; Wang T; O'Brien EC; Samsky MD; Pura JA; Lokhnygina Y; Rogers JG; Hernandez AF; Craig D; Bowles DE; Milano CA; Shah SH; Januzzi JL; Felker GM; Patel CB
    JACC Heart Fail; 2015 Jan; 3(1):30-39. PubMed ID: 25447345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble ST2 in end-stage heart failure, before and after support with a left ventricular assist device.
    Tseng CCS; Huibers MMH; Gaykema LH; Siera-de Koning E; Ramjankhan FZ; Maisel AS; de Jonge N
    Eur J Clin Invest; 2018 Mar; 48(3):. PubMed ID: 29325227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary function assessment post-left ventricular assist device implantation.
    Sajgalik P; Kim CH; Stulak JM; Kushwaha SS; Maltais S; Joyce DL; Joyce LD; Johnson BD; Schirger JA
    ESC Heart Fail; 2019 Feb; 6(1):53-61. PubMed ID: 30311748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mortality in status 2 patients listed for heart transplantation in the United States: Will understanding cause of death help justify implantation of left ventricular assist devices into less sick patients?
    Morris AA; Chen C; Laskar SR; Smith AL; Vega JD
    Int J Cardiol; 2019 Feb; 276():185-190. PubMed ID: 30482444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
    Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exercise performance of chronic heart failure patients in the early period of support by an axial-flow left ventricular assist device as destination therapy.
    Compostella L; Russo N; Setzu T; Compostella C; Bellotto F
    Artif Organs; 2014 May; 38(5):366-73. PubMed ID: 24117945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.